Sudden withdrawal of carbamazepine increases cardiac sympathetic activity in sleep

Neurology. 2001 Nov 13;57(9):1650-4. doi: 10.1212/wnl.57.9.1650.

Abstract

Objective: To evaluate the cardiac autonomic effects of abrupt withdrawal of carbamazepine (CBZ) during sleep in patients with epilepsy.

Background: The pathophysiology of sudden unexpected death in epilepsy (SUDEP) is uncertain, with ictal or peri-ictal cardiorespiratory compromise appearing probable. Risk factors for SUDEP include multiple antiepileptic drugs (AED), poor compliance, and abrupt AED withdrawal. The spectral analysis of the beat-to-beat heart rate variability (HRV) displays two main components: low frequency (LF), representing sympathetic and parasympathetic influence and high frequency (HF), representing parasympathetic influence. The LF/HF ratio is commonly regarded as an indicator of sympathovagal balance.

Method: Twelve patients with medically intractable seizures underwent abrupt withdrawal of CBZ to facilitate seizure recording during controlled circuit TV-EEG monitoring. Continuous EKG recording was begun 24 hours before CBZ reduction. Spectral analysis of the HRV was performed during selected samples of non-REM sleep before and after CBZ reduction. Analyses were made at least 6 hours after from (complex) partial and 12 hours from generalized seizures.

Results: The mean LF/HF ratio before withdrawal of CBZ was 2.15 compared with a ratio of 2.65 on day 4 after withdrawal, an increase of 19% (geometric mean; 95% CI, 2% to 34%; Wilcoxon test, z = 2.36; p = 0.018). The ratio increased in 10 patients compared with a decrease in only one patient.

Conclusion: Abrupt withdrawal of CBZ leads to enhanced sympathetic activity in sleep as evidenced by increased LF/HF ratios. Increased sympathetic activity in the setting of seizure-induced hypoxia could predispose to SUDEP.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anticonvulsants / administration & dosage
  • Anticonvulsants / adverse effects*
  • Carbamazepine / administration & dosage
  • Carbamazepine / adverse effects*
  • Electroencephalography
  • Epilepsies, Partial / drug therapy
  • Epilepsies, Partial / physiopathology
  • Epilepsy, Generalized / drug therapy
  • Epilepsy, Generalized / physiopathology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Sleep / physiology*
  • Substance Withdrawal Syndrome / physiopathology*
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / physiopathology*

Substances

  • Anticonvulsants
  • Carbamazepine